CURRENT ACADEMIC ROLE & RESPONSIBILITIES
- Teaching undergraduates, postgraduates, DM residents
- Thesis guide for DM residents
- PhD co-guide
SUBJECTS CURRENTLY TEACHING
|Subject||Semester / Year|
|Degree||Specialisation||Institute||Year of passing|
|MD||Internal Medicine||Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh||December 2012|
|DM||Nephrology||Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh||December 2016|
|Institution / Organisation||Designation||Role||Tenure|
|KMC Manipal||Associate Professor||October 2019 - till date|
|KMC Manipal||Assistant Professor||January 2017-October 2019|
|Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh||Senior Resident (Internal Medicine)||January 2013-September 2013|
Role of remote ischaemic conditioning in prevention of contrast induced nephropathy following percutaneous coronary intervention: a randomised controlled trial
Principal Investigator: Dr. Indu Ramachandra Rao
Co-investigator: Dr. Ganesh Paramasivam, Dr. Ravindra Prabhu, Dr. Shankar Prasad Nagaraju, Dr. Tom Devasia
Funding agencies: ICMR
Brief overview: Remote ischaemic conditioning (RIC) is a technique in which brief periods of ischaemia in a remote vascular bed provides protection against prolonged ischaemia in a distant (target) organ.
-It is a non-invasive, non-pharmacological, safe and virtually cost-free novel technique.
-This study aims to study the effect of RIC on renal outcomes in patients undergoing percutaneous coronary intervention.
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Glomerular diseases, chronic kidney disease, acute kidney injury
Area of Expertise
Interventional nephrology, glomerular diseases
Area of Research
Clinical nephrology: Acute kidney injury, chronic kidney disease, glomerular diseases
Professional Affiliations & Contributions
Member of International Society of Nephrology, ERA-EDTA, Women in Nephrology, Indian Society of Nephrology, Indian Society of Organ Transplantation, Association of Vascular Access and Interventional Renal Physicians (AVATAR)
CD19 TARGETED RITUXIMAB THERAPY IN ADULT CALCINEURIN INHIBITOR RESISTANT,DEPENDENT OR INTOLERANT NEPHROTIC SYNDROME DUE TO IDIOPATHIC MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS
J Am Soc Nephrol. 2016;27: 775A-776A
RITUXIMAB IS AN EFFECTIVE THERAPY FOR CALCINEURIN INHIBITOR RESISTANT/DEPENDENT OR INTOLERANT NEPHROTIC SYNDROME DUE TO IDIOPATHIC MINIMAL CHANGE DISEASE AND FOCAL SEGMENTAL GLOMERULOSCLEROSIS IN ADULTS.
Nephrol Dial Transpl.2016;31(suppl 1): i126-42